灯盏花种植发展现状及对策(4)
[22] 杨生超，萧凤回，文国松，等.灯盏花主要数量性状和相关与通径分析[J].西部林业科学，2009，38(1)：109.
[23] 杨生超，徐绍忠，文国松，等.灯盏花主要数量性状的主成份与聚类分析[J].西部林业科学，2008，37(3)：93.
[24] 林丽飞，刘文英，罗冰，等.灯盏花叶斑病病原菌生物学特征初步研究[J].江苏农业科学，2008，4：113.
[25] 林丽飞，李卫芬，罗晶，等.云南省灯盏花根腐病病原物的分离及鉴定[J].植物保护，2009，35(4)：117.
Research on situation and countermeasure of Erigeron breviscapus
plant production
ZHANG Wei1，2， YANG Sheng-chao1， ZHANG Guang-hui1， SU Bao3*
(1.Yunnan Research Center on Good Agriculture Practice for Dominant Chinese Medicinal Materials，Yunnan Agriculture University， Kunming 650201， China； 2. Honghe University， Mengzi 661100， China；
3. Yunnan Baiyao Group Co.， Ltd.， Kunming 650500， China)
[Abstract] For more than ten years， Erigeron breviscapus has been used for the treatment of cardiovascular and cerebrovascular diseases， it experienced the procedure from wild species to the cultivars， and the quality of drug was rapidly improved. In order to further promote the development of E. breviscapus planting industry， this paper analyzes the development status and existing problems of E. breviscapus planting. Some measures would be come forward， such as strengthen the government′s policy support and industrial regulate， accelerate the industry standard and technological innovation， expand brand effect of E. breviscapus of Yunnan， so that the industry has the health and sustainable development.
[Key words] Erigeron breviscapus； industry development； countermeasure
doi：10.4268/cjcmm20131401, 百拇医药(张薇 杨生超 张广辉 苏豹)
[23] 杨生超，徐绍忠，文国松，等.灯盏花主要数量性状的主成份与聚类分析[J].西部林业科学，2008，37(3)：93.
[24] 林丽飞，刘文英，罗冰，等.灯盏花叶斑病病原菌生物学特征初步研究[J].江苏农业科学，2008，4：113.
[25] 林丽飞，李卫芬，罗晶，等.云南省灯盏花根腐病病原物的分离及鉴定[J].植物保护，2009，35(4)：117.
Research on situation and countermeasure of Erigeron breviscapus
plant production
ZHANG Wei1，2， YANG Sheng-chao1， ZHANG Guang-hui1， SU Bao3*
(1.Yunnan Research Center on Good Agriculture Practice for Dominant Chinese Medicinal Materials，Yunnan Agriculture University， Kunming 650201， China； 2. Honghe University， Mengzi 661100， China；
3. Yunnan Baiyao Group Co.， Ltd.， Kunming 650500， China)
[Abstract] For more than ten years， Erigeron breviscapus has been used for the treatment of cardiovascular and cerebrovascular diseases， it experienced the procedure from wild species to the cultivars， and the quality of drug was rapidly improved. In order to further promote the development of E. breviscapus planting industry， this paper analyzes the development status and existing problems of E. breviscapus planting. Some measures would be come forward， such as strengthen the government′s policy support and industrial regulate， accelerate the industry standard and technological innovation， expand brand effect of E. breviscapus of Yunnan， so that the industry has the health and sustainable development.
[Key words] Erigeron breviscapus； industry development； countermeasure
doi：10.4268/cjcmm20131401, 百拇医药(张薇 杨生超 张广辉 苏豹)